These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19022562)

  • 1. Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells.
    Onyüksel H; Jeon E; Rubinstein I
    Cancer Lett; 2009 Feb; 274(2):327-30. PubMed ID: 19022562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells.
    Rubinstein I; Soos I; Onyuksel H
    Chem Biol Interact; 2008 Jan; 171(2):190-4. PubMed ID: 17499651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.
    Dagar A; Kuzmis A; Rubinstein I; Sekosan M; Onyuksel H
    Drug Deliv Transl Res; 2012 Dec; 2(6):454-62. PubMed ID: 23336096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
    Krishnadas A; Rubinstein I; Onyüksel H
    Pharm Res; 2003 Feb; 20(2):297-302. PubMed ID: 12636171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.
    Onyüksel H; Mohanty PS; Rubinstein I
    Int J Pharm; 2009 Jan; 365(1-2):157-61. PubMed ID: 18793708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
    Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.
    Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
    Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
    Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
    Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Patil Y; Panyam J
    Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.